Education

Continuing Education

The AMRPA 2021 Fall Virtual Educational Conference & Expo is offering credits in the following disciplines:  

  • ACCME
  • ANCC    
  • ACHE 
  • AOTA
  • NYPT 

Credit Totals: 

LIVE (Virtual) Attendance:
Max: 13.25 hours - Conference
Max: 5.25 hours - IRF Boot Camp

Additional Credit Hours available for RECORDED Content:
Max: 5.0 On-demand pre-recorded sessions
Max: 15.0 hours recordings available after live sessions are hosted.
 

Accessing Session Recordings
Within five days after the end of the live event, session recordings will be available to view on the Virtual Conference Platform. Session recordings will be available to view, and evaluate, through December 31, 2021.

CE Evaluations and Certificates
Within one week after the conference, you will receive an email with a link and detailed instructions to complete your online evaluations and print your certificate. There will be separate evaluation forms for the Live Version and Recorded Version of the conference. These evaluations are linked, so you cannot claim live and recorded credit for the same session(s). Credit will only be awarded for session(s) you have attended in full. No partial credit will be awarded. After you have completed the session evaluations, you will immediately be able to print your CE Certificate. It will be important to keep track of the sessions that you have viewed both live and as recordings to complete your evaluation.

 

Utilize the Attendance Tracking Log to track the sessions you attended, live or recorded, and add the available CME/CE credit for each to see the total credit you plan to claim on your evaluation.

For assistance with continuing education, contact AMRPA Education Manager, Melanie Hein.

 

 

Participant Notification

AMRPA

19th Annual AMRPA Educational Conference
Live, October 19 – 27, 2021
Enduring, through October 27, 2022 Online

Acknowledgement of Financial Commercial Support
No in-kind commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.

Satisfactory completion 
Participants must complete an evaluation to receive a certificate of completion.  Your chosen sessions must be attended in their entirety.  Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.  

Accreditation Statement

In support of improving patient care, this live to enduring activity has been planned and implemented by Amedco LLC and AMRPA.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 

Physicians (ACCME)
Amedco LLC designates the live sessions of this activity for a maximum of 18.50 AMA PRA Category 1 CreditsTM and the enduring sessions for an additional 20.00 AMA PRA Category 1 CreditsTM for a total of 38.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses (ANCC)
Amedco LLC designates the live sessions of this activity for a maximum of 17.50 ANCC contact hours and the enduring sessions for an additional 20.00 contact hours for a total of 37.50 contact hours.

 

All CME activities must adhere to the ACCME’s content validation requirements. If/when any specific recommendations involving clinical medicine in a CME activity are made, they must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis. In addition, all CME presentations must avoid commercial bias.  All presenters must must complete a disclosure that names any financial relationships or discussion of unlabeled/investigational uses of a medicine or device. 

Health Care Executives:  
AMRPA is authorized to award 37.50 hours of pre-approved ACHE Qualified Education credit for this program toward advancement, or recertification, in the American College of Healthcare Executives. Participants in this program who wish to have the continuing education hours applied toward ACHE Qualified Education credit must self-report their participation. To self-report, participants must log into their MyACHE account and select “My Education Credit” to log hours earned.

The American Occupational Therapy Association, Inc.:  
This conference is approved for 3.45AOTA CEU. The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by AOTA. AMRPA is approved AOTA Provider #6595.

Target Audience: Physicians, Nurses, Healthcare Executives, Occupational Therapists and Physical Therapists
Educational Level: All levels
Complete session descriptions, learning objectives, educational Level and AOTA classifications for individual sessions are available to view on the Virtual Conference Platform.

Calculating AOTA CEUs

CEUs = contact hours
                 10 hours

AMRPA is an AOTA Approved Provider of professional development. Course Approval ID# 03170. This blended/hybrid activity is offered at 3.45 CEUs (34.50 contact hours), Intermediate Level, Professional Issues. AOTA does not endorse specific course content, products, or clinical procedures.

 

New York State Board of Physical Therapy
AMRPA has been approved as a registered sponsor of continuing education for physical therapists and physical therapist assistants by the New York State Education Department Office of the Professions. Physical Therapy credit for this event is approved for 34.50 clock hours. (4.14 CEU)

Calculate CEUs using the following 2-step formula:
1. Contact Hour = 50 minutes (Thus 1 clock hour would by 60 minutes ÷ 50 minutes = 1.2 contact hours.)
2. CEUs = contact hours ÷ 10 hours

*Participants are responsible for ensuring that their state board will accept credits approved by another state for re-licensure.

Description:

Shifts in technology, compliance guidelines, payment policy, and patient care guidelines can affect rehabilitation providers from year to year. The AMRPA 2020 Educational Conference & Expo will focus on innovative strategies and best practices in patient care, compliance, operations, and advocacy related to inpatient rehabilitation hospitals and units, outpatient rehabilitation centers, and other medical rehabilitation providers, ensuring that attendees can adapt to the shifts listed above.

Learning Objectives:

After completing this activity,  you should be able to:

  • Apply innovative and interdisciplinary strategies to improve patient care, outcomes, and equity in the rehabilitation setting.
  • Identify key concerns related to regulatory changes, compliance standards, quality reporting and payment trends in IRF utilization.
  • Discuss the impact of COVID-19 on rehabilitation facilities and units, from patient care to regulatory compliance and how to move forward.

Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.  All of these relationships were treated as a conflict of interest, and have been resolved.  (C7 SCS 6.1-­‐6.2, 6.5)

All individuals in a position to control the content of CE are listed. If their name is not listed below, they disclosed that they had no relevant financial relationships.      

First Name

Last Name

Commercial Interest : Relationship

Diana

Aey

NA

Andrea

Aguirre

NA

Wendy

Albertson

NA

Allison

Albrycht

NA

Monica

Alexanderson

NA

Russ

Bailey

NA

Shirley

Baymiller

NA

Kate

Beller

NA

Michele

Beltram

NA

Robert

Bianchi

NA

Mandy

Bodily-Bartrum

NA

Jennifer

Bogner

NA

Kristy

Borrows

NA

Breanna

Brannan

NA

Kristin

Brooks

NA

Crystal

Brooks

NA

Sara

Browning

NA

Melissa

Burns

NA

JoAnn

Cabacungan

NA

Ken

Caldera

NA

Tim

Callahan

NA

Terrence

Carolan

NA

Jennifer

Carotenuto

NA

Thomas

Cayias

NA

Elissa

Charbonneau

NA

Nancy

Christensen Mayer

NA

Peggy

Cline

NA

Ronald

Connelly

NA

John

Corcoran

NA

Sarah

Covert

NA

Julia

Cowan

NA

Nancy

Crow

NA

Kelley

Crozier

NA

Richard

Curtis

NA

Barbara

Darkangelo

NA

Jamie

Dietrich

NA

Deborah

Doherty

NA

Stephanie

Dunn

NA

Alberto

Esquenazi

Ipsen, Allergan, Merz: Research Grant Site Principal Investigator; Ossur: Corporate Board Member; Ipsen, Allergan: Scientific/Medical Advisory Board Member

Neil

Fedders

NA

Alberto

Fiandaca

NA

Elizabeth

Follis

NA

Chase

Frye

NA

Manuel

Garcia-Gaona

NA

Jaime

Gillespie

NA

Jonathan

Gold

NA

Leigh

Golembiewski

NA

Barbara

Goodspeed

NA

Eliza

Greer

NA

Jolene

Grovum

NA

Scott

Grubman

NA

Molly

Gurak

NA

Ruth

Hallas

NA

Regan

Harrell

NA

Johnny

Harrison

NA

Eileen

Hartranft

NA

Erin

Healer

NA

Melanie

Hein

NA

Nahir

Henry

NA

Julie

Hensler-Cullen

NA

Deborah

Hogue

NA

Emily

Holmer

NA

Danielle

Housman

NA

Christina

Howard

NA

Jennifer

Huber

NA

Cris

Huerta

NA

Kristin

Hull

NA

Lindsay

Humphrey

NA

Suzanne

Kauserud

NA

James

Kendig

NA

Cathy

Knight

NA

Joann

Larkins

NA

Robert

Larrison

NA

Maria

Limongello

NA

Michael

Long

NA

Christine

MacDonell

NA

Carla

Maiolini

NA

Chelsea

Manetta

NA

Hurlbutt

Marcie

NA

Michaela

Marshall

NA

Mara

McDermott

NA

Anne Marie

McDonough

NA

Scott

McGee-Plys

NA

Angela

Menlove

NA

Molly

Mesibov

NA

Mallory

Miller

NA

Cheryl

Miller

NA

Erin

Montgomery

NA

David

Monti

NA

Brian

Moore

NA

Kevin

Moser

NA

Zlata

Muhamedagic

NA

Sherry

Mullins

NA

Samantha

Myers

NA

Emily

Nguyen

NA

Patrick

Nicks

NA

Tracey

Nixon

NA

Christopher

Noren

NA

Kristen

O'Brien

NA

Mooyeon

Oh-Park

NA

Rebecca

Orischak

NA

Paul

Osborn

NA

Jacqueline

Osborne

NA

Mia

Palazzo

NA

Trevor

Paris

NA

Sinyoung

Park

NA

Kate

Parkin

NA

Jason

Peoples

NA

Stephan

Peron

NA

Kim

Pickerel

NA

Christopher

Plastaras

NA

Janet

Pue

NA

Jnise

Ramsey

NA

Mark

Reed

NA

Katherine

Reilly

NA

Sydney

Richards

NA

Steven

Richman

NA

Kent

Riddle

NA

Brandon

Rivera-Melo

NA

Robert

Rowe

NA

Hilary

Sample

NA

Karl

Sandin, MD, MPH

NA

Amanda

Schindler

NA

Caroline

Schnakers

NA

Naomi

Senkeeto

NA

Julieanne

Shulman

NA

Kara

Simpson

NA

Jane

Snecinski

NA

Gail

Solomon

NA

Ali

Spencer

NA

Frederick

Stal

NA

Lisa

Stanley

NA

Amelia

Stocking

NA

Angela

Stolfi

NA

Shamim

Tejani

NA

Peter

Thomas

NA

Erika

Trovato

NA

Stacey

Turner

NA

Michelle

Valenti

NA

Mary

Van de Kamp

NA

Daniel

Walter

NA

Joe

Walters

NA

Lisa

Werner

NA

Kara

Williams

NA

Susanne

Yeakel

NA

Elizabeth

York

NA

Sonia

Zafra

NA

 

Cancellation Policy
Cancellation notices should be sent to Caleb Hudzik. Cancellations received before September 1, 2021, will receive a refund, minus a $100 cancellation fee. After September 1, 2021, a cancellation fee of $200 or 50% of registration paid, whichever is greater, will be charged and any balance refunded. If the registration amount paid is less than or equal to $200, no refund will be given. No refunds will be issued after October 1, 2021, or for no-shows. In the event that an activity is cancelled by AMRPA, registrants will be contacted via email with instructions for refund or transfer of their registration fee to a future AMRPA event.

Accommodations
If you require special assistance to register for an event or access online content, please contact Caleb Hudzik (or 202-207-1100) at AMRPA Headquarters to inform us of your special needs. 

Grievance Policy
AMRPA will comply with all legal and ethical responsibilities to be non-discriminatory in promotional activities, program content and in the treatment of program participants. The monitoring and assessment of compliance with these standards will be responsibility of the Education Director in consultation with the Education Chair and clinical director from committee. We do our best to anticipate problems and, when they do present themselves, will attempt to alleviate complaints as quickly as possible. When a complaint, either verbally or written, is received, the following guidelines are followed with respect to achieving resolution:

(1)    Complaints relative to a speaker or workshop leader, contents of instructional materials being presented, or an individual educational style being utilized, the individual voicing disapproval is requested to place his/her comments in writing. An AMRPA representative will convey these comments to the speaker, assuring the confidentiality of the grieved individual.
(2)    If the complaint concerns a continuing education activity, its content, level of presentation, or facilities in which the event is being held, the representative in charge will attempt to resolve the matter as expeditiously as possible. If the offered resolution (resolutions offered may include, but not be limited to partial/full refund of registration fees paid; credit toward future event) not satisfactory to the individual filing the complaint, then further action may be taken as follows.
(3)    The individual is requested to place his/her complaint in writing to the attention of the Education Director, American Medical Rehabilitation Providers Association 529 14th Street NW, Suite 1280, Washington, DC 20045. The complaint is then reviewed by the Education Director in consultation with the Clinical Director and Education Advisor. A written response will be issued within 30 days of receipt of the written complaint.

Frequently Asked Questions?

Review the Continuing Education FAQ! If you need further assistance, contact AMRPA Education Manager Melanie Hein.

ACCME Requirements

  1.  Information for Learners. Information on needs, expected results, and purpose or objectives will be provided to learners by AMRPA. These will be framed in terms of physician change or health status improvement which is in keeping with our CME mission.
  2. Content Validation. AMRPA expects that all of its CME activities will adhere to the ACCME’s content validation value statements. Specifically, all the recommendations involving clinical medicine in a CME activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis. Please contact AMRPA if you do not feel your presentation can meet these standards.
  3. Safeguards against Commercial Bias. AMRPA expects that the content or format of CME activities and related materials will promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. We employ several strategies to ensure the absence of commercial bias and you are integral to their successful implementation.
    1. We will be disclosing to our learners before the activity whether or not you have relevant financial relationships. If, on the basis of the information you provide, we determine that you have relevant financial relationships with commercial interests that create a conflict of interest with respect to your role in this activity, together we will determine and document a strategy or strategies to resolve that conflict of interest.
    2. We also remind you that CME must give a balanced view of therapeutic options. Use of generic names will contribute to this impartiality. If your CME educational material or content includes trade names, trade names from several companies should be used where available, not just trade names from a single company.
  4.  Measurements of Effectiveness. AMRPA will be seeking feedback from the learners on the effectiveness of this CME activity through evaluations. We will be seeking information on what changes the learners will make as a result of the presentations (oral and posters).
  5. Educational Materials. Educational materials that are a part of this activity, such as slides and published abstracts cannot contain any advertising, trade names, or product-group messages.
  6. If you have any questions relating to continuing education credits or guidelines, please feel free to contact AMRPA Education Manager Melanie Hein.